P. DavidMozleyMD

PubMed

• 18 citations
  18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease.
  Yeona Kang, Claire Henchcliffe, Ajay Verma, Shankar Vallabhajosula, Bin He
  Journal of Neuroimaging. 2019-01-01
• 912 citations
  Neuropsychological Function in Schizophrenia: Selective Impairment in Memory and Learning
  Andrew J. Saykin, Ruben C. Gur, Raquel E. Gur, P. David Mozley, Lyn Harper Mozley
  Archives of General Psychiatry. 1991-07-01
• 49 citations
  Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
  Dawn C. Matthews, Xiangling Mao, Kathleen Dowd, Diamanto Tsakanikas, Caroline S. Jiang
  Brain. 2021-06-18

Journal Articles

• Cortical Laminar Binding of PET Amyloid and Tau Tracers in Alzheimer Disease  
  J Nucl Med, 1/1/2015
• 11C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists  
  J Nucl Med, 1/1/2014
• Repeatability of quantitative FDG-PET/CT and contrast enhanced CT in recurrent ovarian carcinoma: test retest measurements for tumor FDG uptake, diameter and volume  
  Clinical Cancer Res, 1/1/2014
• 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokenitics, and radiation dosi...  
  J Nucl Med, 1/1/2013
• Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer  
  Translational Oncology, 1/1/2012
• PET imaging shows equivalent dynamic human brain NK1-receptor occupancy following single-dose administration of IV fosaprepitant versus oral aprepitant  
  Clin Pharmacol Ther, 1/1/2012
• A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging  
  Radiology, 1/1/2011
• X-Ray computed tomography: Semiautomated volumetric analysis of late-stage lung tumors as a basis for response assessments  
  International J Biomed Imaging, 1/1/2011
• Biodistribution and radiation dosimetry of a positron emission tomographic ligand, [18F]-SP203, to image metabotropic glutamate subtype 5 receptors in humans  
  Eur J Nucl Med Molecular Imaging, 1/1/2010
• Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder  
  Eur Neuropsychopharmacol, 1/1/2010
• Change in lung tumor volume as a biomarker of treatment response: A critical review of the evidence  
  Annals Oncology, 1/1/2010
• Data sets for the qualification of volumetric CT as a quantitative imaging biomarker in lung cancer  
  Optics Express, 1/1/2010
• The use of volumetric CT as an imaging biomarker in lung cancer  
  Academic Radiol, 1/1/2010
• Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarker  
  Academic Radiol, 1/1/2010
• Report of Task Force II: Best Practices in the Use of Medical Imaging Techniques in Clinical Trials  
  Drug Information Journal, 1/1/2008
• Human Biodistribution and Radiation Dosimetry of the Tachykinin NK1 Antagonist Radioligand [18F]SPA-RQ: Comparison of Thin -Slice, Bisected, and 2-D Planar Image Analysis  
  J Nucl Med, 1/1/2007
• Dopamine transporter binding in smokers and nonsmokers  
  Clinical Nuclear Medicine, 1/1/2007
• Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [(99m)Tc]TRODAT-1 and SPECT  
  Phys Med Biol, 1/7/2006
• Molecular imaging: A tool for developing central nervous system drugs  
  J Nucl Med, 1/1/2006
• Characterization of dose dependent norepinephrine transporter blockade by atomoxetine in human brain using 11C MeNER PET  
  J Cerebral Blood Flow Metab, 1/1/2005
• Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease  
  J Nucl Med, 1/1/2005
• Nuclear imaging in the pharmaceutical industry: the cost-value-benefit-risk equation  
  Am Pharma Rev, 1/1/2005
• Weaving single photon imaging into new drug development  
  J Molec Imaging Biol, 1/1/2005
• Differences in [99mTc] TRODAT-1 SPECT Binding to Dopamine Transporters in Patients With Multiple System Atrophy and Parkinson's Disease  
  Eur J Nucl Med Biol, 1/1/2005
• Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates  
  Nucl Med Comm, 1/1/2005
• Join now to see all

Books/Book Chapters

• Radiology 
  Chapter: PET of the Musculoskeletal System 
  Editors: Taveras J, Ferrucci J.Lippincott, Williams & Wilkins, Philadelphia, PA2001
• Refractory Depression: Current Strategies and Future Directions 
  Chapter: Assessment of adrenocortical activity in refractory depressin: Steroid suppression with ketoconazole 
  Page 199 - 210Editors: Nolen WA, Zohar J, Roose SP, Amsterdam JD.John Wiley & Sons, Chichester, England1994
• Biological Basis of Schizophrenic Disorders 
  Chapter: Midlatency auditory evoked responses and neuroimaging in schizophrenia 
  Page 43 - 59Editors: Nakazawa T.Japan Scientific Societies Press, Tokyo, Japan1991